LONDON--(BUSINESS WIRE)--As a part of its new healthcare provider analytics article series, Quantzig, a premier analytics services provider, today announced the completion of its recent case study – ‘Rwe Analytics: Improving Patient Outcomes for an Api Manufacturing Company’
The case study also offers comprehensive insights on:
- The benefits of patient outcomes analytics
- Why businesses should leverage patient outcomes analytics to better drive outcomes
Our patient outcomes analytics industry experts help organizations to improve patient care and connect to patients on an emotional level. Get in touch with them right away.
Active Pharmaceutical Ingredient, or API, is a component that is used in the manufacture of pharmaceutical drug formulations and has therapeutic effects on the body. It constitutes the main ingredient or the part of the drug that helps cure diseases. The rise in the occurrence of chronic diseases is expected to drive the growth of the global API market in the coming years. Also, the increasing demand has posed major challenges for manufacturers in the active pharmaceutical ingredient market.
At Quantzig, we analyze the current business scenario using real-time dashboards to help global enterprises operate more efficiently. Our ability to help performance-driven organizations realize their strategic and operational goals within a short span using data-driven insights has helped us gain a leading edge in the analytics industry. To help businesses ensure business continuity amid the crisis, we’ve curated a portfolio of advanced healthcare provider analytics solutions that not just focus on improving profitability but help enhance stakeholder value, boost customer satisfaction, and help achieve financial objectives.
Our patient outcomes analytics solutions provide best-in-class frameworks to assist healthcare organizations to get maximum sales and insights out of every customer relationship and interaction. Request a free demo below to know more.
“Patient outcomes analytics helps you to devise a platform to aggregate patient data from several sources which can enhance the effectiveness of your drug formulations,” says a patient outcomes analytics analytics expert at Quantzig.
1: Enhance drug efficiency
2: Improve patient outcomes
With the innumerable and unique challenges that have unfolded in today’s rapidly changing API market, real world evidence analytics acts as a potential lifeline that helps enhance patient outcomes through improved drug formulations. However, there’s no denying that several challenges exist in the API market, but with the help of real world data, companies can gain a stronger foothold in the market. Quantzig’s patient outcomes analytics solutions help healthcare companies to reduce the cost of care and gain a competitive advantage in the market. Request a FREE proposal to gain detailed insights into our complete portfolio of analytics services.
Quantzig’s Healthcare Analytics Capabilities Include:
- Clinical trial reporting and analytics
- Pharmacovigilance analytics
- Drug pricing and promotion analytics
- Patient analytics
To know more about our healthcare provider analytics solutions, visit: https://bit.ly/2AjUDrm
Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 15 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision making. Today, our firm consists of 120+ clients, including 45 Fortune 500 companies. For more information on our engagement policies and pricing plans, visit: https://www.quantzig.com/request-for-proposal